Relationship between Atherogenic Dyslipidaemia and Lipid Triad and Scales That Assess Insulin Resistance

Abstract

Background: Atherogenic dyslipidaemia (AD) and lipid triad (LT) are characterised by high triglyceride levels together with low HDL and normal or high LDL cholesterol and are favoured by a persistent state of insulin resistance (IR), which increases the release of free fatty acids from abdominal adipose tissue. This alteration in the lipid profile favours the accelerated development of atherosclerosis, which is the most important cause of morbidity and mortality in all countries in the developed and developing world. One of the elements that plays a major role in the genesis of AD is IR. The aim of this study was to determine the relationship between variables that assess atherogenic risk (AD and LT) and scales that assess the risk of presenting insulin resistance. Methods: A descriptive cross-sectional study of 418,343 workers was conducted to evaluate atherogenic dyslipidaemia and lipid triad; a relationship with three insulin resistance risk scales (Triglycerides/HDL, TyG index, METS-IR) was established. The usefulness of IR risk scales for predicting AD and LT was calculated by applying ROC curves, obtaining the area under the curve (AUC) and cut-off points with their sensitivity, specificity, and Youden index. Multivariate analysis was performed by binary logistic regression. Results: The prevalence of high-risk values for insulin resistance with all of the scales is much higher in people with AD and LT compared to those without. The ROC curves present us with an AUC with the three insulin resistance risk scales for the two dyslipidaemias studied with figures ranging between 0.856 and 0.991, which implies that the results are good/very good. Conclusions: A relationship between atherogenic dyslipidaemia and the three insulin resistance risk scales assessed is revealed, with higher IR mean values and prevalence in people with atherogenic dyslipidaemia and lipid triad. The three scales make it possible to adequately classify the presence of AD and LT. The highest AUC is presented by the triglycerides/HDL scale, with a result close to 1. METS-IR is the most recommended formula to estimate insulin resistance.

An Update on the Interdisciplinary Dental Care Approach for Geriatric Diabetic Patients

“…Muscle and adipose tissue, in particular, become less sensitive to glucose and more resistant to insulin as we age [142]. Increasing insulin resistance in the elderly has been linked to abdominal obesity, elevated circulation levels of free fatty acids, and inflammatory markers such as tumor necrosis factors and interleukin 6 [143,144]. Drugs with negative effects on carbohydrate metabolism, such as diuretics, betablockers, and glucocorticoids, also contribute to the onset of hyperglycemia in the elderly.…”

Estado del arte: Nuevos biomarcadores en el diagnóstico del Síndrome Metabólico

“…El valor predictivo positivo de la medición de miR-33a y miR-122 es útil para identificar a los individuos en riesgo de desarrollar síndrome metabólico y enfermedades cardiovasculares (Huang et al, 2023). Sin embargo, como con otros biomarcadores, el valor predictivo negativo puede ser más bajo, lo que indica que un resultado negativo de la prueba no excluye completamente la presencia de la enfermedad (Paublini et al, 2023).…”

Association between Surrogate Markers of Insulin Resistance and the Incidence of Colorectal Cancer in Korea: A Nationwide Population-Based Study

“…Another surrogate marker is the triglyceride-to-high-density lipoprotein cholesterol (TG/HDL-C) ratio, a simple indicator of IR that is strongly associated with HOMA-IR [ 17 , 18 ]. The most recently proposed measure of IR is the metabolic score for IR (METS-IR), which has been used as a new surrogate marker for IR because of its association with the development of type 2 diabetes mellitus, cardiovascular disease, dyslipidemia, and hyperuricemia [ 19 , 20 , 21 , 22 ].…”